Effects of superoxide dismutase topical treatment on human skin radiofibrosis: A pathological study

Breast

Volumn 5, Issue 2, 1996, Pages 75-81

  Benyahia, B ^a   Campana, F ^a   Perdereau, B ^a   Gez, E ^b   Fourquet, A ^a   Magdelenat, H ^a  

^a INSTITUT CURIE   (France)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PUNCH BIOPSY; RADIATION INJURY; SKIN FIBROSIS; SMOOTH MUSCLE; SPECTROMETRY; TOPICAL DRUG ADMINISTRATION;

EID: 0029988551     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(96)90125-3     Document Type: Article

References (29)

1. Levitt S H, Perez C A. Breast cancer: principles and practice of radiation oncology. Radiation Oncology. Philadelphia: JB Lippincott Company, 1987; 730-792.
2. Van Limbergen E, Rijnders A, Van der Schueren E. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol 1989; 16: 253-267.
3. Wazer D E, Di Petrillo T, Schmidt-Ulrich R. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early breast carcinoma. J Clin Oncol 1992; 10: 356-363.
4. Hopewell J W. The skin: its structure and response to ionizing radiation. Int J Radiat Biol 1990; 57 (4): 751-773.
5. Mc Lennan G, Oberley L W, Autor A P. The role of oxygen-derived free radicals in radiation-induced damage and death of non-dividing eucaryotic cells. Radiat Res 1980; 84: 122-132.
6. Del Maestro R F, Thaw H H, Bjork J. Free radicals as mediators of tissue injury. Acta Physiol Scand 1980; 429 (suppl.): 43-57.
7. Ulrich R L, Casarett G W. Inter-relationship between the early inflammatory response and subsequent fibrosis after radiation exposure. Radiat Res 1977; 72: 107-121.
8. Frick J, Danner C, Kunit G. Clinical experience wit orgotein in urologic affections. Eur J Rheumatol Inflamm 1981; 4: 260-263.
9. Baillet F, Housset M, Michelson A M, Puget K. Treatment of radiofibrosis with liposomal Superoxide dismutase. Preliminary results of 50 cases. Free Rad Res Commun 1986; 1 (6): 387-394.
10. Carson S, Vogin E E, Huber W. Safety tests of orgotein, an inflammatory protein. Toxicol Appl Pharmacol 1973; 26: 184-202.
11. Petkau A, Changue C A. Scientific basis for the clinical use of Superoxide dismutase. Cane Treat Rev 1986; 13; 17-44.
12. Michelson A M. Toxicity of Superoxide dismutase. In: Michelson A M, McCord I M, Fridovich I, eds. Superoxide and Superoxide dismutase. London: Academic Press, 1977; 245-256.
13. Labib A, Perdereau B, Girodet B. Evaluation de l'effet radioprotecteur de la SOD liposomiale (lipsod) dans la prevention des complications rectales de la radiothérapie. Bul Cane (Paris) 1991; 78 (6): 504 (abstract).
14. Perdereau B, Campana F, Vilcoq J R et al. Superoxyde dismutase (Cu/Zn) en application cutanée dans le traitement des fibroses radioinduites. Bull Cancer (Paris) 1994; 81: 659-669.
15. Vilcoq J R, Calle R, Schlienger P. Irradiation techniques for conservative irradiation of localized breast cancer. In: Harris J M, Hellman S, Silen W, eds. Conservative management of breast cancer. New surgical and radiotherapeutic techniques. Philadelphia: J B Lippincott, 1983; 213-224.
16. Fourquet A, Campana F, Rosenwald J C. Breast irradiation in the lateral decubitus position: technique of the Institut Curie. Radiother Oncol 1991; 22: 261-265.
17. Housset M, Baillet F, Michelson A M, Puget K. Action of liposomal Superoxide dismutase on measurable radiation-induced fibrosis. Ann Med Int (Paris) 1989; 140: 365-367.
18. Junqueira L C U, Bignolas G, Brentani R R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochemical J 1979; 11: 447-455.
19. Bullock G R, Petrusz P Techniques in immunocytochemistry. London: Academic Press, 1982.
20. Canney P A, Dean S. Transforming growth factor β: a promoter of late connective tissue injury following radiotherapy? Br J Radiol 1990; 63: 620-623.
21. Benyahia B, Magdelenat H. Immunohistochemical characterization of human γ-irradiated skin. Bull Cancer Radiother 1993; 80: 126-134.
22. Edsmyr F, Huber W, Menander K B. Orgotein efficacy in ameliorating side effects due to radiation therapy. Eur J Rheumatol Inflamm 1981; 4 (2): 228-236.
23. Klug D, Rabani J, Fridovich I. A direct demonstration of catalytic action of Superoxide dismutase through the use of pulse-radiolysis. J Biol Chem 1972; 15: 4839-4842.
24. Henderson B, Miller A. Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. Radiat Res 1986; 108: 196-205.
25. Cividalli A, Adami M, De Tomasi F. Orgotein as a radioprotector in normal tissues. Experiments on mouse skin and a murine adenocarcinoma. Acta Radiol Oncol 1985; 24: 273-277.
26. Nielsen O S, Overgaad J, Overgaard M. Orgotein in radiation treatment of bladder cancer. A report on allergic reaction and lack of radioprotective effect. Acta Radiol Oncol 1987; 26: 101-104.
27. Joned J B, Cramer H M, Inch W R. Radioprotective effect of free radical scavenging enzymes. J Otolaryngol 1990; 19: 299-306.
28. Sporn M B, Roberts A B. Transforming growth factor b: recent progress and new challenges. J Cell Biol 1992; 119: 1017-1021.
29. Sappino A P, Schürch W, Gabbiani G. Biology of disease. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990; 63 (2): 144-161.